Related Experiment Video
Updated: Feb 17, 2026

09:28
Isolation of Primary Human Colon Tumor Cells from Surgical Tissues and Culturing Them Directly on Soft Elastic Substrates for Traction Cytometry
Published on: June 4, 2015
16.2K
Tumor stiffness extends its grip on the metastatic microenvironment.
Steven E Reid1, Sara Zanivan2,3
1Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Skåne, Sweden.
Molecular & Cellular Oncology
|December 7, 2017
Summary
Tumor stiffness promotes cancer cell spread by increasing N-Cadherin. This involves CCN1-mediated signaling in endothelial cells, enhancing cancer cell circulation and dissemination.
Area of Science:
- Oncology
- Biomedical Engineering
- Cell Biology
Background:
- Tumor microenvironment stiffness is a critical factor in cancer progression.
- Cancer cell dissemination, or metastasis, is a complex process involving interactions between cancer cells and the host environment.
- Endothelial cells play a crucial role in regulating the passage of cells into and out of the circulation.
Purpose of the Study:
- To investigate the role of tumor stiffness in mediating cancer cell dissemination.
- To elucidate the molecular mechanisms by which increased tumor stiffness promotes cancer cell spread.
- To identify key signaling pathways involved in stiffness-induced cancer cell migration.
Main Methods:
- Utilized in vitro models to mimic tumor stiffness and endothelial cell interactions.
- Investigated the expression of CCN1 and N-Cadherin in response to varying stiffness.
- Analyzed the impact of CCN1 and N-Cadherin modulation on cancer cell adhesion and transmigration.
Main Results:
- Increased tumor stiffness significantly upregulated CCN1 expression in endothelial cells.
- CCN1 mediated autocrine signaling, leading to elevated N-Cadherin levels on endothelial cells.
- Higher N-Cadherin expression resulted in more stable interactions with cancer cells, promoting their dissemination.
Conclusions:
- Tumor stiffness is a key driver of cancer cell dissemination through CCN1-mediated endothelial activation.
- Targeting the stiffness-induced CCN1-N-Cadherin axis may offer therapeutic strategies to inhibit cancer metastasis.
- Understanding these biomechanical cues is crucial for developing effective anti-cancer therapies.
Related Concept Videos
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K

